You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial
|
|---|---|
| Published in |
Lancet Oncology, February 2017
|
| DOI | 10.1016/s1470-2045(17)30086-4 |
| Pubmed ID | |
| Authors |
Johan Erlandsson, Torbjörn Holm, David Pettersson, Åke Berglund, Björn Cedermark, Calin Radu, Hemming Johansson, Mikael Machado, Fredrik Hjern, Olof Hallböök, Ingvar Syk, Bengt Glimelius, Anna Martling |
X Demographics
The data shown below were collected from the profiles of 58 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 10 | 17% |
| Spain | 7 | 12% |
| France | 3 | 5% |
| Brazil | 2 | 3% |
| United Kingdom | 2 | 3% |
| Germany | 1 | 2% |
| Switzerland | 1 | 2% |
| Peru | 1 | 2% |
| Australia | 1 | 2% |
| Other | 7 | 12% |
| Unknown | 23 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 25 | 43% |
| Practitioners (doctors, other healthcare professionals) | 16 | 28% |
| Scientists | 15 | 26% |
| Science communicators (journalists, bloggers, editors) | 2 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 503 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 2 | <1% |
| Spain | 1 | <1% |
| Japan | 1 | <1% |
| Unknown | 499 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 77 | 15% |
| Other | 55 | 11% |
| Student > Master | 45 | 9% |
| Student > Ph. D. Student | 44 | 9% |
| Student > Postgraduate | 40 | 8% |
| Other | 115 | 23% |
| Unknown | 127 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 270 | 54% |
| Nursing and Health Professions | 18 | 4% |
| Biochemistry, Genetics and Molecular Biology | 11 | 2% |
| Unspecified | 7 | 1% |
| Social Sciences | 6 | 1% |
| Other | 38 | 8% |
| Unknown | 153 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 135. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 January 2021.
All research outputs
#312,850
of 25,837,817 outputs
Outputs from Lancet Oncology
#373
of 6,943 outputs
Outputs of similar age
#6,878
of 432,229 outputs
Outputs of similar age from Lancet Oncology
#9
of 141 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,943 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.3. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,229 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 141 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.